Boston Scientific buys Resectr tissue resection device from Distal Access

Boston Scientific (NYSE:BSX) said today that it acquired the Resectr tissue resection device from Distal Access for an undisclosed amount. The buy covers the gynecology and urology portfolio of Salt Lake City-based Distal Access, Boston Scientific said. The Resectr device is designed for polypectomies to remove uterine polyps. “The Resectr device is exactly the type of innovation we need to help make healthcare more cost-effective and accessible for physicians and their patients,” urology & pelvic health president David Pierce said in prepared remarks. “This acquisition is part of our commitment to advance comprehensive solutions for women’s health that can help physicians provide high-quality care.” Marlborough, Mass.-based Boston Scientific said it plans to integrate the purchase into its urology & pelvic health business. The buyout is not expected to affect earnings this year or in 2017, the company said. The post Boston Scientific buys Resectr tissue resection device from Distal Access appeared first on MassDevice.
Source: Mass Device - Category: Medical Equipment Authors: Tags: Mergers & Acquisitions Wall Street Beat Women's Health Boston Scientific Distal Access Source Type: news